DoctorWhat

Buy Bottom In Two to Four Weeks - Sell One To Two Months Later

DoctorWhat Mis à jour   
NASDAQ:CRNT   Ceragon Networks Ltd.
This is in a downward channel with a period of two to three months. We appear to be coming down from a local maximum, with approximately two to four weeks until another bottom. When the price gets to the bottom trend line, it's time to buy. Then watch for a retest of the upper trend line. Sell, or wait for a break out at your leisure. Happy trading! For fun, educational purposes only, of course.

Alternative scenario: we make a double bottom around $1.70, above the lower trend line, before rebounding.
Transaction en cours:
Now is the time to start watching for an entry, and possibly even scaling into a small position.
Transaction en cours:
I have not yet begun scaling in. With the market dumping that's ongoing, I would not be surprised to see this one get much closer to $1 before turning around.
Commentaire:
Feeling that $1 incoming this week, though we may be moving into resistance. COVID-19 has accelerated and amplified the anticipated drop.
Commentaire:
Bounced hard off $1 (actually $0.99). If you had bought at $1, you could have sold a day later for +15%. This one may breach $1 again if the plunge continues. Get ready to scale in...some day.
Trade fermée: cible de profit atteinte:
Commentaire:
Two months to the day after I started this idea, and we're back at a local max. If you want to keep trading the channel, and assuming it doesn't break out from here, look for another bottom in about four weeks, give or take a week.
Trade fermée: cible de profit atteinte:
Ideal buy was $1. Channel is invalidated, but breached around $2.07. If I had played this as smartly as I could have, I'd have doubled my money.

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.